Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Neurosci Res ; 58(4): 593-8, 1999 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-10533051

RESUMO

Interleukin-1 beta (IL-1beta) is an inflammatory cytokine whose expression is elevated in brain during seizures, ischemia, and injury. Expression of IL-1beta and its receptor can also be observed in normal brain. Platelet-activating factor (PAF) is also a dual mediator that promotes neuronal plasticity responses as well as inflammation. We have determined the role of PAF in the regulation of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) genes by IL-1beta in rat primary hippocampal cultures. As assessed by reverse transcriptase/polymerase chain reaction (RT/PCR), recombinant mouse IL-1beta (1 nM) led to an induction of COX-2 mRNA which peaked at 2 hours, declined to baseline levels by 4 hours, began to rise again by 6 hours, and remained elevated at 24 hours post-treatment. iNOS mRNA was also induced, but unlike COX-2, its abundance peaked at 4 hours and decreased by 6 hours to a plateau lasting through 24 hours. Pretreatment with PAF antagonist BN50730 blocked induction of COX-2 mRNA by 2-hour IL-1beta treatment, and 2-hour treatment with the PAF analog mcPAF mimicked the effects of IL-1beta on COX-2 mRNA levels. Following injury, synaptic plasticity changes may be affected by IL-1beta-PAF-COX-2 neuronal signaling.


Assuntos
Hipocampo/enzimologia , Interleucina-1/fisiologia , Isoenzimas/biossíntese , Neurônios/enzimologia , Óxido Nítrico Sintase/metabolismo , Fator de Ativação de Plaquetas/farmacologia , Prostaglandina-Endoperóxido Sintases/biossíntese , Animais , Azepinas/farmacologia , Ciclo-Oxigenase 2 , Indução Enzimática/efeitos dos fármacos , Indução Enzimática/fisiologia , Hipocampo/citologia , Hipocampo/efeitos dos fármacos , Camundongos , Neurônios/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II , Fator de Ativação de Plaquetas/análogos & derivados , Inibidores da Agregação Plaquetária/farmacologia , Ratos , Proteínas Recombinantes/farmacologia , Tienopiridinas , Triazóis/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...